alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 74.3102 FD&C Blue No. 2. ( a ) *Identity.* The color additive FD&C Blue No. 2 shall conform in identity to the requirements of § 74.102(a)(1).
( b ) *Specifications.* ( 1 ) The color additive FD&C Blue No. 2 for use in coloring surgical sutures shall conform to the following specifications and shall be free from impurities other than those named to the extent that such impurities may be avoided by current good manufacturing practice: Sum of volatile matter at 135 °C (275 °F) and chlorides and sulfates (calculated as sodium salts), not more than 15 percent. Water insoluble matter, not more than 0.4 percent. Isatin-5-sulfonic acid, not more than 0.4 percent. Isomeric colors, not more than 18 percent. Lower sulfonated subsidiary colors, not more than 5 percent. Lead (as Pb), not more than 10 parts per million. Arsenic (as As), not more than 3 parts per million. Total color, not less than 85 percent.
( 2 ) The color additive FD&C Blue No. 2-Aluminum Lake on alumina for use in bone cement shall be prepared in accordance with the requirements of § 82.51 of this chapter.
( c ) *Uses and restrictions.* ( 1 ) The color additive FD&C Blue No. 2 may be safely used for coloring nylon (the copolymer of adipic acid and hexamethylene diamine) surgical sutures for use in general surgery subject to the following restrictions: ( i ) The quantity of color additive does not exceed 1 percent by weight of the suture;
( ii ) The dyed suture shall conform in all respects to the requirements of the United States Pharmacopeia XX (1980); and
( iii ) When the sutures are used for the purposes specified in their labeling, the color additive does not migrate to the surrounding tissues.
( 2 ) The color additive FD&C Blue No. 2-Aluminum Lake on alumina may be safely used for coloring bone cement at a level not to exceed 0.1 percent by weight of the bone cement.
( 3 ) Authorization and compliance with these uses shall not be construed as waiving any of the requirements of sections 510(k), 515, and 520(g) of the Federal Food, Drug, and Cosmetic Act with respect to the medical device in which the color additive FD&C Blue No. 2 and the color additive FD&C Blue No. 2-Aluminum Lake on alumina are used.
( d ) *Labeling.* The labels of the color additive FD&C Blue No. 2 and the color additive FD&C Blue No. 2-Aluminum Lake on alumina shall conform to the requirements of § 70.25 of this chapter.
( e ) *Certification.* All batches of FD&C Blue No. 2 and its lake shall be certified in accordance with regulations in part 80 of this chapter.
[64 FR 48290, Sept. 3, 1999]
# L_2018282EN.01000401.xml

| 12.11.2018 | EN | Official Journal of the European Union | L 282/4 |
| --- | --- | --- | --- |

12.11.2018

EN

Official Journal of the European Union

L 282/4

---

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1694

of 7 November 2018

conferring protection under Article 99 of Regulation (EU) No 1308/2013 of the European Parliament and of the Council on the name ‘Oolde’ (PDO)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1308/2013 of the European Parliament and of the Council of 17 December 2013 establishing a common organisation of the markets in agricultural products and repealing Council Regulations (EEC) No 922/72, (EEC) No 234/79, (EC) No 1037/2001 and (EC) No 1234/2007 (1), and in particular Article 99 thereof,

Whereas:

| (1) | In accordance with Article 97(2) and (3) of Regulation (EU) No 1308/2013, the Commission has examined the application to register the name ‘Oolde’ sent by the Netherlands and has published it in the Official Journal of the European Union (2). |
| --- | --- |

(1)

In accordance with Article 97(2) and (3) of Regulation (EU) No 1308/2013, the Commission has examined the application to register the name ‘Oolde’ sent by the Netherlands and has published it in the Official Journal of the European Union (2).

| (2) | No statement of objection has been received by the Commission under Article 98 of Regulation (EU) No 1308/2013. |
| --- | --- |

(2)

No statement of objection has been received by the Commission under Article 98 of Regulation (EU) No 1308/2013.

| (3) | In accordance with Article 99 of Regulation (EU) No 1308/2013, the name ‘Oolde’ should be protected and entered in the register referred to in Article 104 of that Regulation. |
| --- | --- |

(3)

In accordance with Article 99 of Regulation (EU) No 1308/2013, the name ‘Oolde’ should be protected and entered in the register referred to in Article 104 of that Regulation.

| (4) | The measures provided for in this Regulation are in accordance with the opinion of the Committee for the Common Organisation of the Agricultural Markets, |
| --- | --- |

(4)

The measures provided for in this Regulation are in accordance with the opinion of the Committee for the Common Organisation of the Agricultural Markets,

HAS ADOPTED THIS REGULATION:

Article 1

The name ‘Oolde’ (PDO) is hereby protected.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 7 November 2018.

For the Commission,

On behalf of the President,

Phil HOGAN

Member of the Commission

---

(1)  
  OJ L 347, 20.12.2013, p. 671.

1

(2)  
  OJ C 199, 11.6.2018, p. 3.

2

---
AFS-11-238-E

April 7, 2011 

 Exemption No. 9846A 

 Regulatory Docket No. FAA-2008-1121 

Mr. Peter H. Lee 

Director, Aviation Career Campus 

Metro Technology Centers 

1900 Springlake Drive 

Oklahoma City, OK 73111 

Dear Mr. Lee: 

This letter is to inform you that we have granted your petition to extend Exemption No. 9846. 

It explains the basis for our decision and describes its effect. 

The Basis for Our Decision 

By letter dated March 30, 2011, you petitioned the Federal Aviation Administration (FAA) on 

behalf of Metro Technology Centers (Metro Technology) for an extension of Exemption No. 

9846. That exemption from § 65.75(a) of Title 14, Code of Federal Regulations (14 CFR) 

allows Metro Technology to administer the aviation mechanic general (AMG) written test to 

students immediately following successful completion of the general curriculum, prior to 

meeting the experience requirements of 14 CFR § 65.77. 

In your petition, you indicate there has been no change in the conditions and reasons relative 

to public interest and safety that were the basis for granting the original exemption. 

The FAA has determined that good cause exists for not publishing a summary of the petition 

in the Federal Register. The requested exemption would not set a precedent, and any delay in 

acting on this petition would be detrimental to Metro Technology. 
 2

Our Decision 

Under the authority contained in 49 U.S.C. 40113 and 44701, which the FAA Administrator 

has delegated to me, I hereby grant Metro Technology Centers an exemption from 

14 CFR § 65.75(a) to the extent necessary to: 

1. Approve students for retesting within 30 days after failure without requiring a 

signed statement certifying that additional instruction has been given in the 

failed area; and 

2. Administer the AMG written test to students immediately following successful 

completion of the general curriculum, before meeting the experience 

requirements of § 65.77. 

The Effect of Our Decision 

Our decision extends the termination date of Exemption No. 9846 to April 30, 2013, unless 

sooner superseded or rescinded. 

All conditions and limitations of Exemption No. 9846 remain the same. This letter must be 

attached to, and is a part of, Exemption No. 9846. 

Sincerely, 

/s/ 

Raymond Towles 

Acting Director, Flight Standards 

 Service
EXHIBIT 10.1

Summary of Director Compensation



|                                                                                                                                                       |  |                   
|------------------------------------------------------------------------------------------------------------------------------------------------------ |  | ------------------
|Description                                                                                                                                            |  | Amount*           
|Annual Retainer for attendance (in person or telephonically) at the regularly scheduled Board and Committee meetings                                   |  | $20,000           
|                                                                                                                                                       | 
|Fee per meeting for attendance (in person or telephonically) at any of the five (5) regularly scheduled Board meetings                                 |  | $2,000            
|                                                                                                                                                       | 
|Restricted Stock Award                                                                                                                                 |  | $100,000          
|                                                                                                                                                       | 
|Fee per meeting for attendance (in person or telephonically) at any specially called meeting of the Board, for which attendance is requested in person |  | $2,500 per meeting
|                                                                                                                                                       | 
|Fee per meeting for attendance (in person or telephonically) at any specially called committee meeting at which attendance is requested in person      |  | $1,250 per meeting



|* | The compensation referred to in the above table is only available to independent directors.
|- | -------------------------------------------------------------------------------------------
<PAGE>   1
                                                                     EXHIBIT 5.1
                        [COOLEY GODWARD LLP LETTERHEAD]





August 30, 1999

Vixel Corporation
11911 Northcreek Parkway South
Bothell, Washington 98011

Ladies and Gentlemen:

You have requested our opinion with respect to certain matters in connection
with the filing by Vixel Corporation (the "Company") of a Registration Statement
on Form S-1 (the "Registration Statement") with the Securities and Exchange
Commission (the "Commission") covering an underwritten public offering of up to
four million two hundred fifty five thousand (4,255,000) shares of Common Stock,
including five hundred fifty five thousand (555,000) shares of Common Stock
which the underwriters have the option to purchase to cover over-allotments
(collectively the "Common Stock").

In connection with this opinion, we have (i) examined and relied upon the
Registration Statement and related Prospectus, the Company's Restated
Certificate of Incorporation and Bylaws, as currently in effect, and the
originals or copies certified to our satisfaction of such records, documents,
certificates, memoranda and other instruments as in our judgment are necessary
or appropriate to enable us to render the opinion expressed below; and (ii)
assumed that the Restated Certificate of Incorporation, as set forth in Exhibit
3.2 of the Registration Statement, shall have been duly approved and filed with
the office of the Delaware Secretary of State.

On the basis of the foregoing, and in reliance thereon, we are of the opinion
that the Common Stock, when sold and issued in accordance with the Registration
Statement and related Prospectus, will be validly issued, fully paid and
non-assessable.

We consent to the reference to our firm under the caption "Legal Matters" in the
Prospectus included on the Registration Statement and to the filing of this
opinion as an exhibit to the Registration Statement.

Very truly yours,

COOLEY GODWARD LLP

By: /s/ Gregory B. Abbott
    ---------------------------
    Gregory B. Abbott
# C_2018328EN.01003702.xml

| 17.9.2018 | EN | Official Journal of the European Union | C 328/37 |
| --- | --- | --- | --- |

17.9.2018

EN

Official Journal of the European Union

C 328/37

---

Judgment of the General Court of 12 July 2018 — Hitachi Metals v Commission

(Case T-448/14) (1)

((Competition - Agreements, decisions and concerted practices - European market for power cables - Decision finding an infringement of Article 101 TFEU - Single and continuous infringement - Proof of the infringement - Duration of participation - Public distancing - Calculation of the fine - Gravity of the infringement - Unlimited jurisdiction))

(2018/C 328/50)

Language of the case: English

Parties

Applicant: Hitachi Metals Ltd (Tokyo, Japan) (represented by P. Crowther and C. Drew, Solicitors)

Defendant: European Commission (represented by C. Giolito, H. van Vliet and J. Norris-Usher, acting as Agents, and by M. Gray, Barrister)

Re:

Action pursuant to Article 263 TFEU for annulment of Commission Decision C(2014) 2139 final of 2 April 2014 relating to a proceeding under Article 101 [TFEU] and Article 53 of the EEA Agreement (Case AT.39610 — Power cables) in so far as it concerns the applicant and, in the alternative, an application for a reduction in the amount of the fine imposed on the applicant in that decision.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Hitachi Metals Ltd to pay the costs. |
| --- | --- |

2.

Orders Hitachi Metals Ltd to pay the costs.

---

(1)  OJ C 282, 25.8.2014.

---
I 

118TH CONGRESS 

2D SESSION H. R. 7468 

To ensure that United States diplomats and officials of the U.S. Section 

of the International Boundary and Water Commission are able to advance efforts seeking compliance by the United Mexican States with 

the 1944 Treaty on Utilization of Waters of the Colorado and Tijuana 

Rivers and of the Rio Grande. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 28, 2024 

Ms. DE LA CRUZ (for herself, Mr. CUELLAR, Mr. WEBER of Texas, Mr. SELF, 

Mr. CRENSHAW, Mr. JACKSON of Texas, Mr. NEHLS, Ms. CROCKETT, 

Mr. SESSIONS, Mr. CARTER of Texas, Ms. VAN DUYNE, Mr. VICENTE

GONZALEZ of Texas, Mr. PFLUGER, Mr. HUNT, Mr. GOODEN of Texas, 

Mr. TONY GONZALES of Texas, Mr. MORAN, Mr. ARRINGTON, Ms. GARCIA of Texas, Mr. BABIN, Mr. MCCAUL, Mr. CLOUD, Mr. FALLON, Mr. 

BURGESS, Mr. WILLIAMS of Texas, Mr. ROY, Mr. ELLZEY, Ms. 

ESCOBAR, Mr. CASTRO of Texas, Mr. LUTTRELL, Mrs. FLETCHER, Mr. 

VEASEY, and Ms. GRANGER) introduced the following bill; which was referred to the Committee on Foreign Affairs 

A BILL 

To ensure that United States diplomats and officials of the 

U.S. Section of the International Boundary and Water 

Commission are able to advance efforts seeking compliance by the United Mexican States with the 1944 Treaty 

on Utilization of Waters of the Colorado and Tijuana 

Rivers and of the Rio Grande. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7468 IH

1 SECTION 1. ADVANCING EFFORTS SEEKING COMPLIANCE 

2 BY MEXICO WITH TREATY ON UTILIZATION 

3 OF WATERS OF THE COLORADO AND TIJUANA 

4 RIVERS AND OF THE RIO GRANDE. 

5 The Secretary of State shall use the voice, vote, diplo6 matic capital, and resources of the United States to ensure 

7 that United States diplomats and officials of the U.S. Sec8 tion of the International Boundary and Water Commission 

9 are able to advance efforts seeking compliance by the 

10 United Mexican States with the Treaty on Utilization of 

11 Waters of the Colorado and Tijuana Rivers and of the Rio 

12 Grande, signed at Washington February 3, 1944, and to 

13 establish understandings to provide predictable and reli14 able future deliveries of water by the United Mexican 

15 States. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
#### § 82.2707a Ext. D&C Yellow No. 7.

The color additive Ext. D&C Yellow No. 7 shall conform in identity with specifications to the requirements of § 74.1707a(a)(1) and (b) of this chapter. Ext. D&C Yellow No. 7 is restricted to use in externally applied drugs and cosmetics.
#### § 822.15 How long must I conduct postmarket surveillance of my device?

The length of postmarket surveillance will depend on the postmarket surveillance question identified in our order. We may order prospective surveillance for a period up to 36 months; longer periods require your agreement. If we believe that a prospective period of greater than 36 months is necessary to address the surveillance question, and you do not agree, we will use the Medical Devices Dispute Resolution Panel to resolve the matter. You may obtain guidance regarding dispute resolution procedures from the Center for Devices and Radiological Health's (CDRH') Web site (*http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHOmbudsman/default.htm.*). The 36-month period refers to the surveillance period, not the length of time from the issuance of the order.

[72 FR 17400, Apr. 9, 2007, as amended at 78 FR 18233, Mar. 26, 2013]
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                                 Date of Report:
                                 April 30, 2003

                        CIT HOME EQUITY LOAN TRUST 2002-2
             (Exact Name of Registrant as Specified in its Charter)

                                    Delaware
                 (State or other jurisdiction of incorporation)

                            (Commission File Number)
                                    333-65554

                        (IRS Employer Identification No.)

                    c/o The CIT Group/Consumer Finance, Inc.
                                   1 CIT Drive
                             Livingston, New Jersey
                                   07039-0491

               Registrants' telephone number, including area code:
                                 (973) 740-5000

                                       N/A
          (Former name or former address, if changed since last report)


<PAGE>

Item 5. Other Events

CIT HOME EQUITY LOAN TRUST 2002-2
MONTHLY SERVICE REPORT

COLLECTION PERIOD:                                                     30-Apr-03
PAYMENT DATE:                                                          27-May-03
DETERMINATION DATE:                                                    21-May-03

The monthly distributions were made to holders of asset backed notes issued by
CIT Home Equity Loan Trust 2002-2 on:
May 27, 2003

Item 7. Financial Statements and Exhibits

(c.)  Exhibits.

      The following are filed herewith. The exhibit numbers correspond with Item
601(b) of Regulation S-K.

      Exhibit No. 20.1      Monthly Servicer Report

<PAGE>

                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized. CIT Home Equity Loan Trust 2002-2

By: JPMorgan Chase Bank, as Trustee

By: Kevin Crombie

Name:  Kevin Crombie
Title: Assistant Vice President/Relationship Manager
Dated: May 27, 2003
# Exhibit 1
Editorial Note on Part 173
Editorial Note: Nomenclature changes to part 173 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; and 81 FR 49896, July 29, 2016.

§ 173.50 Polyvinylpolypyrrolidone. The food additive polyvinylpolypyrrolidone may be safely used in accordance with the following prescribed conditions: ( a ) The additive is a homopolymer of purified vinylpyrrolidone catalytically produced under conditions producing polymerization and cross-linking such that an insoluble polymer is produced.
( b ) The food additive is so processed that when the finished polymer is refluxed for 3 hours with water, 5 percent acetic acid, and 50 percent alcohol, no more than 50 parts per million of extractables is obtained with each solvent.
( c ) It is used or intended for use as a clarifying agent in beverages and vinegar, followed by removal with filtration.
Michigan Supreme Court

Lansing, Michigan

Marilyn Kelly,

 Chief Justice

Michael F. Cavanagh

Elizabeth A. Weaver

Maura D. Corrigan

Robert P. Young, Jr.

Stephen J. Markman

Diane M. Hathaway, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

 _________________________________________ 

 Clerk

January 29, 2010 

0125 

Order 

 

January 29, 2010 

139393 

ROBERT J. ROOSENBERG, M.D., 

Plaintiff-Appellant, 

v SC: 139393 

 COA: 280235 

Kent CC: 04-003796-NM 

JAMES ZERRENNER and 

ZERRENNER & ROANE, 

Defendants-Appellees. 

_________________________________________/ 

 On order of the Court, the application for leave to appeal the May 5, 2009 

judgment of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court.
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.520 Soy leghemoglobin. ( a ) *Identity.* ( 1 ) The color additive soy leghemoglobin is a stabilized product of controlled fermentation of a non-pathogenic and non-toxicogenic strain of the yeast, *Pichia pastoris,* genetically engineered to express soy leghemoglobin protein. Soy leghemoglobin protein is the principal coloring component of the color additive and imparts a reddish-brown color.
( 2 ) Color additive mixtures made with soy leghemoglobin may contain only those diluents that are suitable and are listed in this subpart as safe for use in color additive mixtures for coloring foods.
( b ) *Specifications.* Soy leghemoglobin shall conform to the following specifications and shall be free from impurities, other than those named, to the extent that such impurities may be avoided by good manufacturing practice: ( 1 ) Soy leghemoglobin protein purity on protein basis (weight/weight), not less than 65 percent, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
( 2 ) Lead, not more than 0.4 milligrams per kilogram (mg/kg) (0.4 parts per million (ppm)).
( 3 ) Arsenic, not more than 0.05 mg/kg (0.05 ppm).
( 4 ) Mercury, not more than 0.05 mg/kg (0.05 ppm).
( 5 ) Cadmium, not more than 0.2 mg/kg (0.2 ppm).
( c ) *Uses and restrictions.* Soy leghemoglobin may be safely used in ground beef analogue products such that the amount of soy leghemoglobin protein does not exceed 0.8 percent by weight of the uncooked ground beef analogue product.
( d ) *Labeling.* The label of the color additive and of any mixture prepared therefrom intended solely or in part for coloring purposes must conform to § 70.25 of this chapter.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from the certification requirements of section 721(c) of the Federal Food, Drug, and Cosmetic Act.
[84 FR 37576, Aug. 1, 2019]